Navigation Links
Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice
Date:9/15/2008

. Preclinical studies of ENB-0040 in the "knockout" mouse model of severe hypophosphatasia were recently published in the Journal of Bone and Mineral Research [June 2008:23:777-787] and showed that subcutaneous administration of ENB-0040 significantly improved survival and prevented the skeletal and dental manifestations of the disease.

About Enobia Pharma Inc.

Enobia Pharma Inc., is a private, Montreal based company focused on the development of therapeutics to treat serious bone disorders for which there is no currently approved drug therapy. Enzyme Replacement Therapy for the treatment of hypophosphatasia is the Company's lead program. In 2007 Enobia completed a $40M Series B financing lead by OrbiMed Advisors and CTI Life Sciences.

Company Contact: Julie Anne Smith, (514) 596-2901, extension 214


'/>"/>
SOURCE Enobia Pharma
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Enobia Pharma Raises $40.1 Million Series B Financing
2. Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company
3. Zenobia Therapeutics, Inc. Receives Michael J. Fox Foundation for Parkinsons Research Award for Work on PD-implicated Protein LRRK2
4. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
5. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
8. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
9. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... JERUSALEM, Israel, December 2 ...aluating the preclinical (animal study) safety and... technology from Weill,Cornell Medical College and...eat inherited anemias such as Cooley,s Anemia. ,...nologies to expand, ex vivo,populations of stem/p...
(Date:12/2/2009)...RESTON, Va., Dec. 2 /PRNewswire-Asia-FirstCall/ --...any") (OTC Bulletin Board: EMDY), a leading,produc...a, milk powder and,soybean products in China, toda...he Spring issue of US Food & Drink Executive, ...,000 executives in the food and beverage industry....
(Date:12/2/2009)...CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zent..."), a global biopharmaceutical company focused on ...at the U.S. Food and Drug Administration (FDA) has...PI3K/Akt pathway inhibitor compound, perifosine (K... multiple myeloma. Keryx Biopharmaceuticals, Inc. ...
(Date:12/2/2009)... The Scientist, a leading scientific magazin...rsquo; Evolve “Intelligent” EMCCD came... 10 Innovations of 2009. , ...EMCCD camera from Photometrics ®, a designer...D cameras for the life sciences, was ranked fourth...
Breaking Biology Technology:Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3
...hicago is being welcomed with open arms and open c...nced earlier this week that Clonex Development, I... Commerce Technology Venture Fund (TVF) and Tec...he company purchase new equipment and hire profess...thusiastic to join the dynamic biotechnology envir...
...ystem. Image courtesy of GE Healthcare. Wisconsin...will include $10 million for a grant and loan prog...rd (EMR) systems. , ,"I am committed to ensuring t...care," Doyle said. "That,s why I am pleased to unv...ce potentially dangerous medical errors and unnece...
...its information, which is why content management s... management does your organization really need? , ...livers many benefits to an organization: lower op...er efficiency and a wider range of features for yo...ons to choose from, identifying and implementing t...
Other Biology Technology:Doyle proposes $10M to expand use of electronic medical records 2Doyle proposes $10M to expand use of electronic medical records 3Consider the content when managing information online 2Consider the content when managing information online 3Consider the content when managing information online 4
(Date:12/1/2009)...two different feeding strategies. A large proport... they are generalist predators feeding on other sm... however, are "herbivorous". This is not to say t...r diets consist of plant-derived matter. For examp...s to attract ants, called extra-floral nectar; oth...
(Date:12/1/2009)...s pleased to announce the publication of results f...efficacy and tolerability of its novel, intranasal...chronic rhinosinusitis with nasal polyps in Rhino...nd European Rhinologic Societies. , Chronic rhi... that can significantly reduce a patient,s quality...
(Date:12/1/2009)...disease, nerve cell degeneration plays a crucial r...ssibly be derived from steering the generation and...published in the current issue of the renowned jou... ago, neurogenesis the process of nerve cell deve...ult brain. The textbooks asserted that dead nerve ...
Breaking Biology News(10 mins):Bacterial gut symbionts are tightly linked with the evolution of herbivory in ants 2New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2New source discovered for the generation of nerve cells in the brain 2New Research Shows 3A Neurofeedback is an Evidence Based Treatment for ADHD 4729 1New Research Shows 3A Neurofeedback is an Evidence Based Treatment for ADHD 4729 2Negligible impact on public safety from shark cage diving operations 9272 1Pharmacyclics Announces Subscription Price for Rights Offering 13053 1Pharmacyclics Announces Subscription Price for Rights Offering 13053 2Pharmacyclics Announces Subscription Price for Rights Offering 13053 3
...dy by researchers at Hasbro Childrens Hospital, th... Mount Sinai Hospital, New York, offers new insigh...s in the development of gastrointestinal disease. ...egulator (CFTR) gene codes for a protein also know...d with cystic fibrosis (CF) and a range of digesti...
...ral climate variations, which tend to involve loca... a larger effect on hurricane activity than the mo... this week,s Nature suggests. , In the debate ove...s generally assumed that warmer oceans provide a m...t and intensification. However, several other fact...
...ejo, California) Ossur, an emerging leader in the...l acquisitions and a period of integration, is ple...blished the long-awaited results of a two year cer...he study, Range-of-Motion Restriction and Craniofa... Collars, finds that Ossurs products the Miami J ...
Other Biology News:Study uncovers clues to cystic fibrosis gene dysfunction and gastrointestinal disease 2Climate's remote control on hurricanes 2Mayo Clinic study: Ossur's collars superior in immobilization and reduction of pressure 2
Rabbit Anti-Human Q86SZ3 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Silencer Validated siRNA - with sequence information 20 nmol from Ambion
Silencer Pre-designed siRNA, PAGE purified, annealed from Ambion
...y and reliably amplify unknown genomic DNA using ...le-free, ready-to use components, at an extraordin... are provided in each kit. The BAC End Amplificati... large clones such as P1, YAC and BAC, and localiz...
Biology Products: